GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panbela Therapeutics Inc (STU:X70) » Definitions » Payments on Behalf of Employees

Panbela Therapeutics (STU:X70) Payments on Behalf of Employees


View and export this data going back to 2021. Start your Free Trial

What is Panbela Therapeutics Payments on Behalf of Employees?

Payments on Behalf of Employees only applicable to companies reporting Cash Flow from Operations in direct method.


Panbela Therapeutics (STU:X70) Business Description

Traded in Other Exchanges
Address
712 Vista Boulevard, Suite 305, Waconia, MN, USA, 55387
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X), which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity.